HopeStage
Back to all studies
CompletedEUCTR 2015-000222-11

A phase II, randomised, double-blind, placebo- controlled, multi-site, parallel group clinical trial to examine ketamine as a pharmacological treatment for alcohol dependence in an alcohol dependen...

This historical record does not confirm current site availability.

Historical research recordUnited KingdomAddiction
The study in practice

Understand this study

What did researchers investigate?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations
United Kingdom
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateNot clearly listed
Recruitment status
Completed
Enrollment listed in the registry
0
Sponsor
University College London
Sponsor type
University
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United Kingdom
Age range
Not clearly listed
Official registry ID
EUCTR 2015-000222-11
Official title
Show the full official title

A phase II, randomised, double-blind, placebo- controlled, multi-site, parallel group clinical trial to examine ketamine as a pharmacological treatment for alcohol dependence in an alcohol dependen...

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

United Kingdom

Registry details
Historical country statuses
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University College London, a university.

Want to explore more studies?

Explore studies